Furthermore, in BRCA gene wild-type ovarian cancer cell lines SKOV3 and OVCAR3, nuclear RAD51 foci could be induced by rucaparib, which might be decreased by CHK1 inhibitors 22. This evidence concerns the gene RAD51 and ovarian carcinoma.